Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Guselkumab in Pain: NCT06974474 Clinical Landscape Report 2026
16 October 2026
NCT06974474 clinical landscape for Pain: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Mometasone Furoate in Dermatitis, Atopic: CTRI/2025/05/087075 Clinical Landscape Report 2026
16 October 2026
CTRI/2025/05/087075 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
LPX-TI641 in Plaque psoriasis: NCT06982352 Clinical Landscape Report 2026
16 October 2026
NCT06982352 clinical landscape for Plaque psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Carboplatin in Ovarian Epithelial Carcinoma: NCT06980545 Clinical Landscape Report 2026
16 October 2026
NCT06980545 clinical landscape for Ovarian Epithelial Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Deucravacitinib in Plaque psoriasis: NCT06979453 Clinical Landscape Report 2026
16 October 2026
NCT06979453 clinical landscape for Plaque psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Medroxyprogesterone Acetate in Ovarian Cancer: NCT06979596 Clinical Landscape Report 2026
16 October 2026
NCT06979596 clinical landscape for Ovarian Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Sulodexide in Psoriasis of scalp: NCT06982196 Clinical Landscape Report 2026
16 October 2026
NCT06982196 clinical landscape for Psoriasis of scalp: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Iparomlimab/Tuvonralimab in Uterine Cervical Cancer: NCT06986057 Clinical Landscape Report 2026
16 October 2026
NCT06986057 clinical landscape for Uterine Cervical Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Enlonstobart in Locally Advanced Cervical Carcinoma: NCT06981858 Clinical Landscape Report 2026
16 October 2026
NCT06981858 clinical landscape for Locally Advanced Cervical Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white s…
9 min read
Trastuzumab Rezetecan in Platinum-Sensitive Ovarian Carcinoma: NCT06990516 Clinical Landscape Report 2026
16 October 2026
NCT06990516 clinical landscape for Platinum-Sensitive Ovarian Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Divozilimab in Multiple Sclerosis: NCT06987851 Clinical Landscape Report 2026
16 October 2026
NCT06987851 clinical landscape for Multiple Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Trastuzumab Rezetecan in Platinum-Resistant Primary Peritoneal Carcinoma: NCT06990503 Clinical Landscape Report 2026
16 October 2026
NCT06990503 clinical landscape for Platinum-Resistant Primary Peritoneal Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and develop…